A 12-month subscription to the pill runs the same $249 per month, saving $600 per year
Our team carries five premium brands, so each recommendation fits you, not one product line
Product (Drug Class/Brand) Type 2 Diabetes (T2DM Byetta (exenatide) Victoza (liraglutide) Bydureon BCise (exenatide) Trulicity (dulaglutide) Adlyxin / Lyxumia (lixisenatide) Soliqua (lixisenatide/insulin glargine) FDC Xultophy / iDegLira (liraglutide / insulin degludec) FDC Ozempic (semaglutide) Rybelsus (semaglutide) Mounjaro (tirzepatide) Obesity & Weight Loss Management Saxenda (liraglutide) Wegovy (semaglutide) Zepbound (tirzepatide) Route of Administration Subcutaneous Oral Pipeline Analysis Geography North America (U.S., Canada) Latin America (Brazil, Mexico, Rest of LA) Europe (U.K., Germany, France, Italy, Spain, Rest of EU) Asia Pacific (Japan, China, India, Rest of APAC Rest of the World Company Profiles AstraZeneca plc Eli Lilly and Company Novo Nordisk A/S Sanofi S.A
The results suggested that tirzepatide (Mounjaro) led to slightly higher average weight loss and greater reductions in A1C levels compared to semaglutide (Ozempic)
This is expected and is part of how the medication works, but it makes monitoring important for people with diabetes
